BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38463201)

  • 21. Benefit of Postoperative Radiotherapy for Patients With Nonmetastatic Adrenocortical Carcinoma: A Population-Based Analysis.
    Wu K; Liu X; Liu Z; Lu Y; Wang X; Li X
    J Natl Compr Canc Netw; 2021 Dec; 19(12):1425-1432. PubMed ID: 34902831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical Resection of the Primary Tumor in Stage IV Colorectal Cancer Without Metastasectomy is Associated With Improved Overall Survival Compared With Chemotherapy/Radiation Therapy Alone.
    Gulack BC; Nussbaum DP; Keenan JE; Ganapathi AM; Sun Z; Worni M; Migaly J; Mantyh CR
    Dis Colon Rectum; 2016 Apr; 59(4):299-305. PubMed ID: 26953988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Operative Management of Recurrent and Metastatic Adrenocortical Carcinoma: A Systematic Review.
    Lo WM; Kariya CM; Hernandez JM
    Am Surg; 2019 Jan; 85(1):23-28. PubMed ID: 30760340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adrenalectomy for Secondary Malignancy: Patients, Outcomes, and Indications.
    Wachtel H; Roses RE; Kuo LE; Lindeman BM; Nehs MA; Tavakkoli A; Parangi S; Hodin RA; Fraker DL; James BC; Carr AA; Wang TS; Solórzano CC; Lubitz CC
    Ann Surg; 2021 Dec; 274(6):1073-1080. PubMed ID: 32427760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disparities in access to care and outcomes in patients with adrenocortical carcinoma.
    Hammad AY; Yen TWF; Carr AA; Evans DB; Wang TS
    J Surg Res; 2017 Jun; 213():138-146. PubMed ID: 28601306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary Metastasectomy for Adrenocortical Carcinoma-Not If, but When.
    Carr SR; Villa Hernandez F; Varghese DG; Choo-Wosoba H; Steinberg SM; Teke ME; Del Rivero J; Schrump DS; Hoang CD
    Cancers (Basel); 2024 Feb; 16(4):. PubMed ID: 38398093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Score Predicting Overall Survival After Surgery for Synchronous Metastatic Adrenocortical Carcinoma: A Surveillance, Epidemiology, and End Result-Based Study.
    Wu K; Liu Z; Li X; Lu Y
    Am Surg; 2021 May; 87(5):805-811. PubMed ID: 33228399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adrenocortical carcinoma surgery-surgical extent and approach.
    Vanbrugghe C; Lowery AJ; Golffier C; Taieb D; Sebag F
    Langenbecks Arch Surg; 2016 Nov; 401(7):991-997. PubMed ID: 27412357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. National Treatment Practice for Adrenocortical Carcinoma: Have They Changed and Have We Made Any Progress?
    Tierney JF; Chivukula SV; Poirier J; Pappas SG; Schadde E; Hertl M; Kebebew E; Keutgen X
    J Clin Endocrinol Metab; 2019 Dec; 104(12):5948-5956. PubMed ID: 31361313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Laparoscopic Adrenalectomy on Overall Survival in Patients with Nonmetastatic Adrenocortical Carcinoma.
    Huynh KT; Lee DY; Lau BJ; Flaherty DC; Lee J; Goldfarb M
    J Am Coll Surg; 2016 Sep; 223(3):485-92. PubMed ID: 27238874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do Repeated Operations for Recurrent Colorectal Lung Metastases Result in Improved Survival?
    Menna C; Berardi G; Tierno SM; Andreetti C; Maurizi G; Ciccone AM; D'Andrilli A; Cassiano F; Poggi C; Diso D; Venuta F; Rendina EA; Ibrahim M
    Ann Thorac Surg; 2018 Aug; 106(2):421-427. PubMed ID: 29605599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benefit of Metastasectomy in Renal Cell Carcinoma: A Propensity Score Analysis.
    Maisel F; Smolle MA; Mollnar S; Riedl JM; Barth DA; Seles M; Terbuch A; Rossmann CH; Eisner F; Mannweiler S; Hutterer G; Zigeuner R; Pummer K; Smolle-Jüttner FM; Lindenmann J; Stotz M; Gerger A; Jost PJ; Bauernhofer T; Pichler M; Posch F
    Clin Genitourin Cancer; 2022 Aug; 20(4):344-353. PubMed ID: 35443915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic Role of Ki-67 in Adrenocortical Carcinoma After Primary Resection: A Retrospective Mono-Institutional Study.
    Zhang F; Zhang F; Liu Z; Wu K; Zhu Y; Lu Y
    Adv Ther; 2019 Oct; 36(10):2756-2768. PubMed ID: 31471770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients' Survival.
    Srougi V; Bancos I; Daher M; Lee JE; Graham PH; Karam JA; Henriquez A; Mckenzie TJ; Sada A; Bourdeau I; Poirier J; Vaidya A; Abbondanza T; Kiernan CM; Rao SN; Hamidi O; Sachithanandan N; Hoff AO; Chambo JL; Almeida MQ; Habra MA; Fragoso MCBV
    J Clin Endocrinol Metab; 2022 Mar; 107(4):964-971. PubMed ID: 34850915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cumulative GRAS Score as a Predictor of Survival After Resection for Adrenocortical Carcinoma: Analysis From the U.S. Adrenocortical Carcinoma Database.
    Baechle JJ; Marincola Smith P; Solórzano CC; Tran TB; Postlewait LM; Maithel SK; Prescott J; Pawlik T; Wang TS; Glenn J; Hatzaras I; Shenoy R; Phay JE; Shirley LA; Fields RC; Jin L; Abbott DE; Ronnekleiv-Kelly S; Sicklick JK; Yopp A; Mansour J; Duh QY; Seiser N; Votanopoulos K; Levine EA; Poultsides G; Kiernan CM
    Ann Surg Oncol; 2021 Oct; 28(11):6551-6561. PubMed ID: 33586069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Score Predicting Long-Term Survival after Repeat Resection for Recurrent Adrenocortical Carcinoma.
    Tran TB; Maithel SK; Pawlik TM; Wang TS; Hatzaras I; Phay JE; Fields RC; Weber SM; Sicklick JK; Yopp AC; Duh QY; Solorzano CC; Votanopoulos KI; Poultsides GA
    J Am Coll Surg; 2016 Dec; 223(6):794-803. PubMed ID: 27618748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors.
    Fassnacht M; Dekkers OM; Else T; Baudin E; Berruti A; de Krijger R; Haak HR; Mihai R; Assie G; Terzolo M
    Eur J Endocrinol; 2018 Oct; 179(4):G1-G46. PubMed ID: 30299884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adrenocortical Carcinoma: Impact of Surgical Margin Status on Long-Term Outcomes.
    Margonis GA; Kim Y; Prescott JD; Tran TB; Postlewait LM; Maithel SK; Wang TS; Evans DB; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem A; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solorzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Poultsides GA; Pawlik TM
    Ann Surg Oncol; 2016 Jan; 23(1):134-41. PubMed ID: 26286195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laparoscopic Versus Open Adrenalectomy for Localized/Locally Advanced Primary Adrenocortical Carcinoma (ENSAT I-III) in Adults: Is Margin-Free Resection the Key Surgical Factor that Dictates Outcome? A Review of the Literature.
    Mpaili E; Moris D; Tsilimigras DI; Oikonomou D; Pawlik TM; Schizas D; Papalampros A; Felekouras E; Dimitroulis D
    J Laparoendosc Adv Surg Tech A; 2018 Apr; 28(4):408-414. PubMed ID: 29319399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Operative intervention for recurrent adrenocortical cancer.
    Dy BM; Wise KB; Richards ML; Young WF; Grant CS; Bible KC; Rosedahl J; Harmsen WS; Farley DR; Thompson GB
    Surgery; 2013 Dec; 154(6):1292-9; discussion 1299. PubMed ID: 24238048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.